Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Collaborative Medical Advance Center (BCMAC) is a specialized medical research organization and clinical trial coordinator based in Beijing, China. The center operates as a strategic platform for multi-center clinical research, facilitating collaboration between healthcare providers, academic researchers, and the pharmaceutical industry. BCMAC provides comprehensive services for clinical studies, including protocol design, site management, data monitoring, and statistical analysis, with a strong focus on oncology and chronic disease management. By bridging the gap between laboratory innovation and clinical application, the center plays a significant role in the evaluation and advancement of new medical technologies and therapies within the Chinese healthcare ecosystem. It is frequently involved in large-scale Phase 3 and Phase 4 trials for both domestic and international pharmaceutical sponsors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Collaborative Medical Advance Center.